Strohman was saying this in the face of tremendous hype over gene transplantation and the development of single-gene targeted drugs like Herceptin, Erbitux, Gleevec, Iressa, that have largely been disappointing and very costly.
FORBES: Why You Should Fear Giant Databases With Your DNA